Figure 1
From: The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
Weight change (A) and tumour volume (B) in either non-tumour-bearing mice (▪) or in mice bearing the MAC16 tumour treated with either PBS (♦), AT (▴), AT +Zn2+ (X) or Zn2+ (O) at the doses and schedule as detailed in Materials and methods. Differences from PBS-treated animals are indicated as *P<0.01 or **P<0.001.
